← All diseases Cancer

Melanoma (metastatic)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (27)Meta-analysis (4)Treatment guideline (2)Systematic review (8)Phase 3 study (7)Randomized trial (6)Clinical trial (586)Review article (181)Early study (phase 1 or 2) (54)Case reports (243)Laboratory or animal study (45)Commentary or editorial (17)Retracted publication (2) Studies currently recruiting participants only (39)

Filter

Publications and studies (1866)

• Kindlin-3 and RASSF6 are probable biomarkers for predicting metastasis in cutaneous melanoma. (2021/01/01) ♡
• Mutational landscape of primary and recurrent Ewing sarcoma. (2021/01/01) ♡
• Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics. (2020/12/30) ♡
• Triphenylphosphonium derivatives disrupt metabolism and inhibit melanoma growth in vivo when delivered via a thermosensitive hydrogel. (2020/12/30) ♡
• NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma. (2020/12/30) ♡
• Genetic Variants in Immune Related Genes as Predictors of Responsiveness to BCG Immunotherapy in Metastatic Melanoma Patients. (2020/12/30) ♡
• Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer. (2020/12/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Symptomatic bladder metastasis of malignant melanoma: a case report. (2020/12/29) ♡
• Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ(12,14) prostamide J(2). (2020/12/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation. (2020/12/29) ♡
• Targeted Stat2 deletion in conventional dendritic cells impairs CTL responses but does not affect antibody production. (2020/12/29) ♡
• Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy. (2020/12/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Immunotherapy Induced Myasthenic-Like Syndrome in a Metastatic Melanoma Patient With Amyotrophic Lateral Sclerosis. (2020/12/28) ♡
• Iris extramedullary hematopoiesis in choroidal melanoma. (2020/12/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary gastric melanoma in a young woman: A case report. (2020/12/26) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Black Urine and Methemoglobinemia in the Setting of Sepsis Due to Clostridium Perfringens. (2020/12/24) ♡
• Breast Metastases: Updates on Epidemiology and Radiologic Findings. (2020/12/24) ♡
• Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma. (2020/12/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment of Non-melanoma Skin Cancers in the Absence of Mohs Micrographic Surgery. (2020/12/22) ♡
• Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study. (2020/12/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical Implications of Acquired BRAF Inhibitors Resistance in Melanoma. (2020/12/20) ♡
• NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma. (2020/12/20) ♡
• Regional lymph node infiltration and thick lesions are associated with poor prognosis in high-risk resected melanomas: A retrospective cohort study. (2020/12/16) ♡
• Prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma. (2020/12/16) ♡
• Possible Influence of Weight Gain and Creatinine Levels in Predicting Response to Nivolumab: A Multicenter Analysis. (2020/12/14) ♡
• Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy. (2020/12/07) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metastatic Melanoma Presenting as a Gastric Mass. (2020/12/03) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes. (2020/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. F-18 fluorodeoxyglucose positron emission tomography/computed tomography in conjunctival melanoma with recurrence. (2020/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cancer-related lymphedema: clinical pearls for providers. (2020/12/01) ♡
• Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer. (2020/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical Trials in Metastatic Uveal Melanoma: Current Status. (2020/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metastatic Squamous Cell Carcinoma of the Tonsil Mimicking Choroidal Melanoma. (2020/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Lipid-Producing Ciliochoroidal Melanoma with Expression of HMG-CoA Reductase. (2020/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Acetylsalicylic Acid Exerts Potent Antitumor and Antiangiogenic Effects in Cutaneous and Uveal Melanoma Cell Lines. (2020/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology. (2020/12/01) ♡
• Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysis. (2020/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Possible Precipitation of Acute Coronary Syndrome with Immune Checkpoint Blockade: A Case Report. (2020/12/01) ♡
• Correction to: Thick melanoma in Tuscany. (2020/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Dermoscopic Features of Giant Molluscum Contagiosum in a Patient with Acquired Immunodeficiency Syndrome. (2020/12/01) ♡
• The Histogenetic Model of Melanoma in the Modern Era of Personalized Medicine. (2020/12/01) ♡
• Impact of age-related T cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: a prospective cohort study. (2020/12/01) ♡
• Cutaneous immune-related adverse events in patients with metastatic melanoma on antiprogrammed cell death protein 1 and anticytotoxic T-lymphocyte-associated protein 4 therapy: A retrospective cohort study. (2020/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Melanoma metastatic to the hyoid bone. (2020/11/23) ♡
• Immune-Related Adverse Events in the Older Adult with Cancer Receiving Immune Checkpoint Inhibitor Therapy. (2020/11/21) ♡
• Mechanistic Insights into Synergy between Melanin-Targeting Radioimmunotherapy and Immunotherapy in Experimental Melanoma. (2020/11/18) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis. (2020/11/01) ♡
• Impact on quality of life and autonomy of patients aged over 75 years treated with anti-PD-1 for metastatic melanoma: A single-centre prospective study. (2020/11/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials. (2020/11/01) ♡
• Multiple glomangiomas in a patient with a history of metastatic melanoma. (2020/11/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.